272 related articles for article (PubMed ID: 30270358)
21. PIK3CA-related overgrowth with an uncommon phenotype: case report.
Rotunno R; Diociaiuti A; Pisaneschi E; Carnevale C; Dentici M; El Hachem M
Ital J Pediatr; 2022 May; 48(1):71. PubMed ID: 35551640
[TBL] [Abstract][Full Text] [Related]
22. Updates on Diagnosis and Treatment of PIK3CA-Related Overgrowth Spectrum.
Chen H; Gao W; Liu H; Sun B; Hua C; Lin X
Ann Plast Surg; 2023 May; 90(5S Suppl 2):S209-S215. PubMed ID: 36729078
[TBL] [Abstract][Full Text] [Related]
23. Somatic activating mutations in
Rodriguez-Laguna L; Agra N; Ibañez K; Oliva-Molina G; Gordo G; Khurana N; Hominick D; Beato M; Colmenero I; Herranz G; Torres Canizalez JM; Rodríguez Pena R; Vallespín E; Martín-Arenas R; Del Pozo Á; Villaverde C; Bustamante A; Ayuso C; Lapunzina P; Lopez-Gutierrez JC; Dellinger MT; Martinez-Glez V
J Exp Med; 2019 Feb; 216(2):407-418. PubMed ID: 30591517
[TBL] [Abstract][Full Text] [Related]
24. Cancer-Associated PIK3CA Mutations in Overgrowth Disorders.
Madsen RR; Vanhaesebroeck B; Semple RK
Trends Mol Med; 2018 Oct; 24(10):856-870. PubMed ID: 30197175
[TBL] [Abstract][Full Text] [Related]
25. Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.
Keppler-Noreuil KM; Lozier J; Oden N; Taneja A; Burton-Akright J; Sapp JC; Biesecker LG
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):571-581. PubMed ID: 31490637
[TBL] [Abstract][Full Text] [Related]
26. Identification and Characterization of a Novel Constitutional PIK3CA Mutation in a Child Lacking the Typical Segmental Overgrowth of "PIK3CA-Related Overgrowth Spectrum".
Di Donato N; Rump A; Mirzaa GM; Alcantara D; Oliver A; Schrock E; Dobyns WB; O'Driscoll M
Hum Mutat; 2016 Mar; 37(3):242-5. PubMed ID: 26593112
[TBL] [Abstract][Full Text] [Related]
27. Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase.
Leiter SM; Parker VER; Welters A; Knox R; Rocha N; Clark G; Payne F; Lotta L; Harris J; Guerrero-Fernández J; González-Casado I; García-Miñaur S; Gordo G; Wareham N; Martínez-Glez V; Allison M; O'Rahilly S; Barroso I; Meissner T; Davies S; Hussain K; Temple K; Barreda-Bonis AC; Kummer S; Semple RK
Eur J Endocrinol; 2017 Aug; 177(2):175-186. PubMed ID: 28566443
[TBL] [Abstract][Full Text] [Related]
28. Utility of clinical high-depth next generation sequencing for somatic variant detection in the PIK3CA-related overgrowth spectrum.
Hucthagowder V; Shenoy A; Corliss M; Vigh-Conrad KA; Storer C; Grange DK; Cottrell CE
Clin Genet; 2017 Jan; 91(1):79-85. PubMed ID: 27307077
[TBL] [Abstract][Full Text] [Related]
29. Novel features of PIK3CA-Related Overgrowth Spectrum: Lesson from an aborted fetus presenting a de novo constitutional PIK3CA mutation.
De Graer C; Marangoni M; Romnée S; Delaunoy M; Zaytouni S; D'Haene N; Désir J; Donner C
Eur J Med Genet; 2020 Apr; 63(4):103775. PubMed ID: 31568861
[TBL] [Abstract][Full Text] [Related]
30. Papillary Intralymphatic Angioendothelioma in a Child With
Debelenko L; Mansukhani MM; Remotti F
Pediatr Dev Pathol; 2023; 26(2):166-171. PubMed ID: 36775953
[TBL] [Abstract][Full Text] [Related]
31. mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer.
Elkabets M; Vora S; Juric D; Morse N; Mino-Kenudson M; Muranen T; Tao J; Campos AB; Rodon J; Ibrahim YH; Serra V; Rodrik-Outmezguine V; Hazra S; Singh S; Kim P; Quadt C; Liu M; Huang A; Rosen N; Engelman JA; Scaltriti M; Baselga J
Sci Transl Med; 2013 Jul; 5(196):196ra99. PubMed ID: 23903756
[TBL] [Abstract][Full Text] [Related]
32. Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene.
Maguolo A; Antoniazzi F; Spano A; Fiorini E; Gaudino R; Mauro M; Cantalupo G; Biban P; Maitz S; Cavarzere P
Ital J Pediatr; 2018 Sep; 44(1):110. PubMed ID: 30231930
[TBL] [Abstract][Full Text] [Related]
33. Clinical and genetic analysis of patients with segmental overgrowth features and somatic mammalian target of rapamycin (mTOR) pathway disruption: Possible novel clinical issues.
Romano F; Madia F; De Marco P; Ognibene M; Guerrisi S; Scala M; Iacomino M; Baldassari S; Vercellino N; Manunza F; Tallone R; Pavanello M; Piatelli G; Garaventa A; Zara F; Capra V
Birth Defects Res; 2022 Dec; 114(20):1440-1448. PubMed ID: 36345927
[TBL] [Abstract][Full Text] [Related]
34. Brain Abnormalities in PIK3CA-Related Overgrowth Spectrum: Physician, Patient, and Caregiver Experiences.
Dexheimer J; Mirzaa GM
Adv Ther; 2022 Sep; 39(9):3871-3880. PubMed ID: 35857185
[TBL] [Abstract][Full Text] [Related]
35. Undergrowth Of First Toe In PiK3CA-Related Overgrowth Spectrum (PROS).
Triana P; Sarmiento MDC; Rodriguez-Laguna L; Martinez-Glez V; Lopez-Gutierrez JC
Ann Vasc Surg; 2023 Jan; 88():233-238. PubMed ID: 35878698
[TBL] [Abstract][Full Text] [Related]
36. Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.
Keppler-Noreuil KM; Parker VE; Darling TN; Martinez-Agosto JA
Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):402-421. PubMed ID: 27860216
[TBL] [Abstract][Full Text] [Related]
37. PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations.
di Blasio L; Puliafito A; Gagliardi PA; Comunanza V; Somale D; Chiaverina G; Bussolino F; Primo L
Cell Death Dis; 2018 Jan; 9(2):45. PubMed ID: 29352118
[TBL] [Abstract][Full Text] [Related]
38. Old treatments for new genetic conditions: Sirolimus therapy in a child affected by mosaic overgrowth with fibroadipose hyperplasia.
Leoni C; Onesimo R; Resta N; Patti ML; De Santis R; Bagnulo R; Russo L; Manfredi R; Genuardi M; Zampino G
Clin Genet; 2019 Jul; 96(1):102-103. PubMed ID: 31012097
[TBL] [Abstract][Full Text] [Related]
39. Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors.
Loconte DC; Grossi V; Bozzao C; Forte G; Bagnulo R; Stella A; Lastella P; Cutrone M; Benedicenti F; Susca FC; Patruno M; Varvara D; Germani A; Chessa L; Laforgia N; Tenconi R; Simone C; Resta N
PLoS One; 2015; 10(4):e0123092. PubMed ID: 25915946
[TBL] [Abstract][Full Text] [Related]
40. Vascular malformations syndromes: an update.
Martinez-Lopez A; Salvador-Rodriguez L; Montero-Vilchez T; Molina-Leyva A; Tercedor-Sanchez J; Arias-Santiago S
Curr Opin Pediatr; 2019 Dec; 31(6):747-753. PubMed ID: 31693582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
